WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'5501 Infant (under 12 months) mortality rate: 522
GDP / capita (US$): 2'0481 Child (under 5 years) mortality rate: 782

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 25'366  24'821  24'263  23'692  23'110  18'825  14'629  10'802 
Births 794  788  780  772  761  655  572  474 
Surviving infants 753  747  739  730  720  613  527  429 
Pop. less than 5 years 3'640  3'593  3'529  3'477  3'423  2'860  2'456  1'933 
Pop. less than 15 years 9'800  9'631  9'452  9'294  9'131  7'799  6'410  4'938 
Female 15-49 years 6'512  6'366  6'212  6'039  5'858  4'507  3'328  2'363 

Number of reported case

(Click for retrospective incidence data for Ghana)
Diphtheria 47  66  40 
Japanese encephalitis
Measles 1'613  120  641  101  82  23'068  32'246  82'684 
Mumps 3'780 
Pertussis 63  636  2'651  13'216 
Polio* 104  60  145 
Rubella 272  712  133  459 
Rubella (CRS)
Tetanus (neonatal) 80 
Tetanus (total) 456  79  256  69  219  660  1'045 
Yellow fever 30  155 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ghana)
Vaccine year result method % card seen                                                
BCG 2011  99  EPI   97.6  98  98  100  100  99*  95  71 
DTP1 2011  100  EPI   97.6  92  94  96  96  96  84 
DTP3 2011  97  EPI   97.6  92  91  94  94  93  84  50 
HepB_BD         
HepB3 2011  97  EPI   97.6  92  91  94  94  93 
Hib3 2011  97  EPI   97.6  92  91  94  94  93 
JapEnc         
MCV 2011  94  EPI   97.6  89  91  93  93  86  84  52  16 
MCV2          52 
PCV1          87 
PCV3          56 
Pol3 2011  97  EPI   97.6  91  91  94  94  92  83  50 
Rota1          86 
Rota_last          77 
Rubella1         
TT2plus 2003  50  DHS   83.0  72  76  80  80  76  73  19 
PAB         
VAD1          35  51  13  59  41 
YFV 2011  93  EPI   97.6  89  91  93  93  86  74 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ghana)
BCG 98  98  99  99  99  99  71 
DTP1 92  94  96  96  96  96  80  27 
DTP3 92  91  94  94  93  88  58 
HepB3 92  91  94  94  93 
Hib3 92  91  94  94  93 
MCV 88  91  93  93  86  90  61  16 
PAB 88  88  86  86  86  69  60 
PCV3 43 
Pol3 91  91  94  94  92  88  57 
Rota_last 49 
YFV 88  91  93  93  86  74 

Number of districts in the country 170  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 63
From 80 to 89% 17
From 50 to 79% 19
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
MR 9, 18 months; Yes From September 2013
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes 12-49 years
Td 1st contact; +1, +6 months; +1, +1 year; Yes From September 2013
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010 - 2014  2010-2014  2010-2014  2010-2014  2007-2011  2007-2011  2002-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 170  170  170  170  138  138  138 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 170  170  170  170  138  138  138 
Nº districts with DTP3 coverage >=80% number 136  144  134  153  117  116  108 
% of districts with DTP3 coverage >=80% From 0 to 100% 80  85  79  90  85  84  78 
Nº districts with measles (MCV1) coverage >=95% number 95  75  57  87  58     
% of districts with MCV1 coverage >=95% From 0 to 100% 56  44  34  51  42     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 11        20  54   

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.